R C Bast

No ORCID on file · 9 papers in corpus · active 1983-1998

Study types

  • other 7
  • review 2

Condition tags

  • endometriosis 9
review 1998
The International journal of biological markers ·doi:10.1177/172460089801300402

Over the last 15 years, substantial progress has been made in understanding the potential and the limitations of the CA 125 assay. More than 2000 papers have been published concerning laboratory and clinical studies of CA 125. The original …

other 1997
Gynecologic oncology ·doi:10.1006/gyno.1997.4620

The single most common cause leading to the diagnosis of endometrial cancer is postmenopausal bleeding. Although most patients with early-stage disease (FIGO stage I and II) can be cured, prognosis worsens considerably with increasing stage…

other 1990
Gynecologic oncology ·doi:10.1016/0090-8258(90)90003-4

Primary and metastatic tumor tissues from 21 patients with ovarian epithelial cancer were studied with a panel of 8 monoclonal antibodies. Primary tumors reacted with 1 to 7 antibodies (mean, 3.5). Heterogeneity was observed even within his…

review 1989
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136832

CA 125 is an antigenic determinant on a high-molecular-weight glycoprotein recognized by a monoclonal antibody which was raised using an ovarian cancer cell line as an immunogen. During the last 5 years the studies reviewed in this paper ha…

other 1986
Fertility and Sterility ·doi:10.1016/s0015-0282(16)49333-7

CA-125 is a high-molecular-weight glycoprotein that is expressed on the cell surface of some derivatives of embryonic coelomic epithelium. Based on results of an immunoradiometric assay developed to detect CA-125 in peripheral blood, 82% of…

other 1985
Cancer treatment reports

Recombinant leukocyte alpha interferon (rIFN-alpha A; Hoffmann-La Roche, Inc) was administered to 15 patients with recurrent or persistent ovarian carcinoma. All patients had been previously treated with surgery and combination chemotherapy…

other 1984
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(84)90035-8

CA 125 and CA 19-9 are antigenic determinants associated with human epithelial ovarian carcinomas. Murine monoclonal antibodies have been raised against these determinants, and immunoradiometric assays have been developed to monitor antigen…

other 1983
The New England journal of medicine ·doi:10.1056/NEJM198310133091503

The murine monoclonal antibody OC 125 reacts with an antigen (CA 125) common to most nonmucinous epithelial ovarian carcinomas. An assay has been developed to detect CA 125 in serum. By this assay, only 1 per cent of 888 apparently healthy …

other 1983
American journal of clinical pathology ·doi:10.1093/ajcp/79.1.98

A murine monoclonal antibody, OC125, reacts with a surface component of ovarian tumor cells from humans, but fails to react with normal adult ovarian cells. The spectrum of reactivity of OC125 in ovarian tumors from humans was defined by te…